3 results
Low irisin levels are associated with increased body weight and an adverse metabolic profile
125
Increased insulin sensitivity in individuals with neurofibromatosis type 1
117
Effect of treatment with sitagliptin on somatosensory-evoked potentials and metabolic control in patients with type 2 diabetes mellitus
31